| Financial Year |
March 31 2021 |
| Monetary Funds |
990,811,884.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
509,147,213.12 |
| Advances to Suppliers |
114,910,344.74 |
| Other Receivables |
53,219,717.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
16,224,997.94 |
| Dividend Receivable |
27,000,000.00 |
| Inventories |
609,968,695.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,859,297.43 |
| Total Current Assets |
3,180,421,456.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
666,526,579.63 |
| Investment Properties |
17,018,431.49 |
| Fixed Assetes |
1,946,541,550.44 |
| Under-construction Projects |
45,780,212.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
113,409,632.54 |
| R&D expenses |
-- |
| Goodwill |
11,547,305.29 |
| Long-Term Deferred and Prepaid Expenses |
3,187,022.30 |
| Deferred Income Tax Assets |
31,250,198.70 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,835,549,632.74 |
| Total Assets |
6,015,971,089.58 |
| Short-Term Loans |
1,053,037,015.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
338,646,348.51 |
| Accounts Payable |
291,253,927.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
68,030,763.11 |
| Taxes Payable |
25,875,182.28 |
| Interest Payable |
13,646,981.75 |
| Dividend Payable |
238,138.78 |
| Other payables |
210,534,483.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
13,017,909.55 |
| Sub-Total of Current Liabilities |
2,100,533,396.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,739,970.26 |
| Deferred Income Tax Liabilities |
2,180,826.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
29,858,683.60 |
| Total Liabilities |
2,130,392,079.92 |
| Paid-In Capital(Or Share Stock) |
505,425,000.00 |
| Capital Surplus |
256,822,373.42 |
| Surplus Reserve |
201,651,448.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,216,268,190.75 |
| Minority Stockholder's Interest |
1,705,242,282.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,180,336,727.51 |
| Owner's Equity（Stockholder's Equity） |
3,885,579,009.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,015,971,089.58 |
